| Literature DB >> 35294502 |
Samar Abd ElHafeez1, Mohamed Salem2, Henry J Silverman3.
Abstract
BACKGROUND: Several studies reveal a problematic prevalence of research misbehaviors. There are several potential causes of research misconduct but ensuring that scientists hold attitudes that reflect norms of acceptable behaviors is fundamental. AIM: Our aim was to evaluate the psychometric properties (factor structure and reliability) of an "attitude" scale that we adopted from a questionnaire we previously used to investigate the prevalence of research misbehaviors in the Middle East.Entities:
Mesh:
Year: 2022 PMID: 35294502 PMCID: PMC8926210 DOI: 10.1371/journal.pone.0265392
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Items in the attitude scales.
|
| |
|
| |
| RE_1 | Conducting research involving human subjects without prior approval from an Institutional Review Board or Ethics Committee |
| RE_2 | Use of confidential information about research subjects without their authorization |
| RE_3 | Not obtaining proper informed consent from participants |
|
| |
| DFF_1 | Making up research data |
| DFF_2 | Changing research data without mentioning it |
| DFF_3 | Dropping “outliers” without mentioning it |
| DFF_4 | Selecting only those data that support your hypothesis |
|
| |
| Plag_1 | Publishing results that belong to someone else |
| Plag_2 | Using someone else’s words or ideas without giving proper credit |
| Plag_3 | Submitting a manuscript to a journal that you already published in another journal |
|
| |
| Authorship_1 | Giving authorship credit to someone who has not contributed substantively to a manuscript |
| Authorship_2 | Denying authorship credit to someone who has contributed substantively to a manuscript |
| Authorship_3 | Allowing your name to be put on papers to which you have made no reasonable contribution |
| COI_1 | Awareness of a conflict of interest (e.g., you have a financial interest with a drug company, and you are conducting a study for them) and did not disclose it to either the ethics committee or a journal |
| COI_2 | Compromising the rigor of a study’s design or methodology in response to pressure from a commercial or not for profit funding source |
| COI_3 | Inappropriately altering or suppressing research results in response to pressure from a commercial or not for profit funding source |
|
| |
| SM_1 | I’m concerned about the amount of misconduct that occurs |
| SM_2 | The responsibility for misconduct lies with the principal investigator only |
| SM_3 | Investigators should report instances of research misconduct |
| SM_4 | Investigators should declare conflicts of interest to the appropriate officials |
| SM_5 | I should monitor my trainees’ work to ensure that they are developing into responsible researchers |
Baseline characteristics of the study population N = 254.
| Number | Percentage | |
|---|---|---|
|
| ||
| Male | 96 | 37.9 |
| Female | 157 | 62.1 |
|
| ||
| Egyptian | 183 | 72.1 |
| Lebanese | 29 | 11.4 |
| Bahraini/Others | 42 | 16.5 |
|
| ||
| Academic Faculty | 121 | 47.6 |
| Master, PhD, postdoctoral | 133 | 52.4 |
|
| ||
| Not graduated | 15 | 5.9 |
| BA/BSc | 49 | 19.3 |
| MSc/MPH/other degree | 76 | 29.9 |
| MD/PhD | 114 | 44.9 |
|
| ||
| No | 108 | 42.5 |
| Yes | 146 | 57.5 |
|
| ||
|
| 209 | 82.3 |
|
| 45 | 17.7 |
|
| ||
| Not yet graduated | 15 | 5.9 |
| North America (Canada/USA) | 19 | 7.5 |
| European Union/UK | 27 | 10.6 |
| Middle East/North Africa | 190 | 74.8 |
| Others (Russia, Japan, and Sub-Saharan Africa) | 3 | 1.2 |
*One participant failed to report gender.
Frequency responses to the two “attitude” scales among the study population.
| Attitudes toward acceptability of RCR practices | |||||
|---|---|---|---|---|---|
| RCR Practices | Very Acceptable N (%) | Acceptable N (%) | Neutral N (%) | Unacceptable N (%) | Very Unacceptable N (%) |
| RE_1: Conducting research involving human subjects without prior approval from an REC | 15(5.9) | 7(2.8) | 31(12.2) | 80 (31.5) | 121(47.6) |
| RE_2: Use of confidential information about research subjects without their authorization | 11(4.3) | 7(2.8) | 16(6.3) | 73(28.7) | 147(57.9) |
| RE_3: Not obtaining proper informed consent from participants | 10(3.9) | 6(2.4) | 25(9.8) | 85(33.5) | 128(50.4) |
| DFF_1: Making up research data | 9(3.5) | 8(3.1) | 8(3.1) | 69(27.2) | 160(63.0) |
| DFF_2: Changing research data without mentioning it | 6(2.4) | 7(2.8) | 12(4.7) | 81(31.9) | 148(58.3) |
| DFF_3: Dropping “outliers” without mentioning it | 8(3.1) | 6(2.4) | 28(11) | 99(39.0) | 113(44.5) |
| DFF_4: Selecting only those data that support your hypothesis | 10(3.9) | 13(5.1) | 39(15.4) | 78(30.7) | 114(44.9) |
| Plag_1: Publishing results that belong to someone else | 8(3.1) | 3(1.2) | 6(2.4) | 63(24.8) | 174(68.5) |
| Plag_2: Using someone else’s words or ideas without giving proper credit | 7(2.8) | 6(2.4) | 4(1.6) | 84(33.1) | 153(60.2) |
| Plag_3: Submitting a manuscript to a journal that you already published in another journal | 8(3.1) | 6(2.4) | 11(4.3) | 85(33.5) | 144(56.7) |
| Authorship_1: Giving authorship credit to someone who has not contributed substantively to a manuscript | 9(3.5) | 9(3.5) | 30(11.8) | 102(40.2) | 104(40.9) |
| Authorship_2: Denying authorship credit to someone who has contributed substantively to a manuscript | 10(3.9) | 3(1.2) | 3(1.2) | 75(29.5) | 163(64.2) |
| Authorship_3: Allowing your name to be put on papers to which you have made no reasonable contribution | 6(2.4) | 12(4.7) | 20(7.9) | 92(36.2) | 124(48.8) |
| COI_1: Awareness of a conflict of interest (e.g., you have a financial interest with a drug company, and you are conducting a study for them) and did not disclose it to either the ethics committee or a journal | 6(2.4) | 6(2.4) | 13(5.1) | 94(37.0) | 135(53.1) |
| COI_2: Compromising the rigor of a study’s design or methodology in response to pressure from a commercial or not for profit funding source | 7(2.8) | 4(1.6) | 12(4.7) | 96(37.8) | 135(53.1) |
| COI_3: Inappropriately altering or suppressing research results in response to pressure from a commercial or not for profit funding source | 6(2.4) | 5(2) | 11(4.3) | 84(33.1) | 148(58.3) |
|
| |||||
|
| Strongly agree | Agree | Neutral | Disagree | Strongly Disagree |
| SM_1: I’m concerned about the amount of misconduct that occurs | 63(24.8) | 120(47.2) | 47(18.5) | 15(5.9) | 9(3.6) |
| SM_2: The responsibility for misconduct lies with the principal investigator only | 24(9.4) | 67(26.4) | 24(9.4) | 92(36.2) | 47(18.5) |
| SM_3: Investigators should report instances of research misconduct | 96(37.8) | 120(47.8) | 22(8.7) | 4(1.6) | 12(4.8) |
| SM_4: Investigators should declare conflicts of interest to the appropriate officials | 95(37.4) | 122(48.0) | 25(9.8) | 3(1.2) | 9(3.6) |
| SM_5: I should monitor my trainees’ work to ensure that they are developing into responsible researchers” | 81(31.9) | 87(34.3) | 66(26.0) | 11(4.3) | 9(3.6) |
Descriptive statistics (mean ± SD) of the different items of the attitude questionnaire.
| Variable | Mean ± SD |
|---|---|
|
| |
| RE_1 | 4.12±1.11 |
| RE_2 | 4.33±1.02 |
| RE_3 | 4.24±0.99 |
| DFF_1 | 4.43± 0.96 |
| DFF_2 | 4.41±0.89 |
| DFF_3 | 4.19±0.95 |
| DFF_4 | 4.07 ± 1.08 |
| Plag_1 | 4.54 ± 0.86 |
| Plag_2 | 4.46 ±0.87 |
| Plag_3 | 4.38 ± 0.92 |
| Authorship_1 | 4.11± 0.99 |
| Authorship_2 | 4.49±0.91 |
| Authorship_3 | 4.24± 0.96 |
| COI_1 | 4.36 ±0.87 |
| COI_2 | 4.37±0.87 |
| COI_3 | 4.43±0.86 |
|
| |
| SM_1 | 2.09±0.89 |
| SM_2 | 3.24±1.28 |
| SM_3 | 1.81±0.85 |
| SM_4 | 1.78 ± 0.77 |
| SM_5 | 3.06±1.94 |
Fig 1Scree plot for determining the numbers of factors extracted.
Factor loadings of the different items of the attitude scales: “Attitudes toward the acceptability of RCR practices” and “general attitude toward scientific misconduct”.
| Factor 1 (Attitudes toward the acceptability of RCR practices) | Factor 2 (General attitudes toward scientific misconduct) | |
|---|---|---|
|
| ||
| RE_1 |
| -.035 |
| RE_2 |
| -.079 |
| RE_3 |
| -.039 |
| DFF_1 |
| .021 |
| DFF_2 |
| -.013 |
| DFF_3 |
| -.015 |
| DFF_4 |
| .026 |
| Plag_1 |
| .045 |
| Plag_2 |
| .037 |
| Plag_3 |
| .071 |
| Authorship_1 |
| .033 |
| Authorship_2 |
| .013 |
| Authorship_3 |
| -.003 |
| COI_1 |
| -.041 |
| COI_2 |
| -.010 |
| COI_3 |
| .005 |
|
| ||
| SM_1 | .031 |
|
| SM_3 | .012 |
|
| SM_4 | -.097 |
|
| SM_5 | .075 |
|
|
| 61.005 | 10.236 |
|
| 61.005 | 71.242 |
Fig 2Correlation between the scores of the “attitudes toward the acceptability of RCR practices” and the Research Misconduct Severity Score.
Fig 4Correlation between the scores of the combined attitude scale and the Research Misconduct Severity Score.
Predictors of the attitude scales (“attitudes toward the acceptability of RCR practices”, “general attitudes toward research misconduct”, and the “combined attitude scale”).
| Variable | Attitude to the acceptability of RCR practices AOR | General attitude to research misconduct AOR | Combined attitude scale AOR |
|---|---|---|---|
| Age | 0.07 (-0.12–0.27), p = 0.46 | 0.03 (-0.01–0.07), p = 0.09 | 0.09 (-0.11–0.30), p = 0.38 |
|
| |||
| Male | 1 | 1 | 1 |
| Female | 0.97 (-2.57–3.98), p = 0.67 | -0.14 (-0.80–0.53), p = 0.68 | 1.06 (-2.57–4.68), p = 0.57 |
|
| |||
| Bahraini/Other | 1 | 1 | 1 |
| Egyptian | -1.16 (-6.04–3.72), p = 0.64 | -0.68 (-1.63–0.28), p = 0.17 | -1.87 (-7.07–3.34), p = 0.48 |
| Lebanese | 0.17 (-6.46–3.72), p = 0.64 | -0.73 (-2.04–0.57), p = 0.27 | 0.25 (-6.86–7.37), p = 0.94 |
|
| |||
| Academic Faculty | 1 | 1 | 1 |
| Master, PhD, postdoctoral, | 2.30 (-2.35–6.95), p = 0.33 | -0.82 (-1.74–0.100), p = 0.08 | 1.51 (-3.51–6.53), p = 0.55 |
|
| |||
| Not yet graduated | 1 | 1 | 1 |
| BA/BSc | 10.72 (3.15–18.28), p = 0.006 | 1.99 (0.52–3.47), p = 0.008 | 12.85 (4.81–20.90), p = 0.002 |
| MSc/MPH/other degree | 10.41 (2.48–18.34), p = 0.01 | 2.29 (0.75–3.83), p = 0.004 | 12.95 (4.56–21.34), p = 0.003 |
| MD/PhD | 6.00 (-2.89–14.90), p = 0.19 | 2.11(0.38–3.85), p = 0.02 | 8.62 (-0.84–18.08), p = 0.07 |
|
| 3.42 (0.13–6.70), p = 0.04 | 0.63 (-0.02–1.28), p = 0.06 | 3.86 (0.33–7.38), p = 0.03 |
|
| 1.78 (-3.20–6.76), p = 0.48 | -0.69 (-1.66–0.29), p = 0.17 | 0.81(-4.50–6.12), p = 0.76 |
*AOR: Adjusted odds ratio.